UNSPSC 51263315: Trigevolol mesilate or mesylate

This classification denotes the mesylate form of a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L2D8DE8S32. European Medicines Agency schedules Trigevolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11294MIG. Trigevolol generally arises in the molecular formula C21H28N2O7.

UNSPSC 51263315 Trigevolol mesilate or mesylate is a Commodity code that in practice does not map to recent state and local procurement activity. The single identifiable opportunity in the recent record—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems for community health initiatives, which does not align with the code's pharmaceutical specification. The mismatch suggests either miscoding in the source data or that trigevolol mesilate purchasing by state and local bodies is not currently surfacing in available procurement records.

No additional state or local contract opportunities under this code are present in the recent activity block. The Seminole County solicitation, while titled against UNSPSC 51263315, represents acquisition of emergency opioid-reversal medications and drug disposal systems rather than the beta-blocker compound the code nominally describes. Given the absence of relevant opportunities and the clear misalignment of the single posting, this code shows negligible current procurement interest at the state and local level and does not warrant active pursuit at this time.